The Hearing Panel decided “that a period of 2 years ineligibility is imposed upon ZHOU Mi for the first violation of the BWF Anti-doping Regulations. The period of ineligibility commences from the date of the provisional suspension, 4 August 2010”.
The Hearing was the result of an Adverse Analytical Finding of a sample taken from ZHOU Mi in late June as part of the BWF’s ‘out-of-competition’ testing programme. ZHOU Mi tested positive to Clenbuterol, a Class 1 Anabolic Agent on the WADA Prohibited List of substances.
“BWF is fortunate that this is the first case that the BWF has ruled on for a number of years. The case sends a strong message to elite athletes in the sport who need to be aware of Prohibited Substances and the consequences of taking these – either deliberately or inadvertently,” said Thomas Lund, BWF COO.
Zhou Mi (HK) in the proceedings acknowledged that she had taken some common over-the-counter medication but was unaware whether or not it had contained any prohibited substance.
“The BWF together with WADA conduct both ‘out-of competition’ and ‘in-competition’ testing on a regular basis and athletes need to be aware that they are ultimately responsible for everything they ingest – whether it is taken deliberately or inadvertently” Lund added. “And this case shows that for a first offence, the punishment is severe”.
The sanction means that ZHOU Mi cannot participate in any badminton at the international, national and local level for a period of 2 years.
To read more click on Hong Kong BA media release, BWF media release and Doping Hearing Panel decision on the above issue.